
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Soft tissue tumors
Skeletal muscle
Alveolar rhabdomyosarcoma
Reviewer: Vijay Shankar, M.D. (see Reviewers page)
Revised: 21 February 2013, last major update November 2012
Copyright: (c) 2003-2013, PathologyOutlines.com, Inc.
Subtypes discussed below: anaplastic variant,
solid variant
Definition
=========================================================================
● High grade round cell malignancy with solid and alveolar growth and partial skeletal muscle differentiation
● Resembles lymphoma
Sites
=========================================================================
● Deep muscles of extremities, axial muscles or perineum
Clinical features
=========================================================================
● 20% of all rhabdomyosarcomas
● More common in early to mid-teens but all ages affected
● Neonatal cases have poor prognosis, are associated with skin and brain metastases
(Cancer 2001;92:1613)
● Rapid growing, often high stage at presentation
Case reports
=========================================================================
● Infant with perineal tumor (Arch Pathol Lab Med 2002;126:982)
● 2 year old girl with pleural effusion and ovarian mass (Arch Pathol Lab Med 2003;127:e56)
● 2 year old girl with tumor of face (An Bras Dermatol 2011;86:363)
● 51 year old woman with cerebral tumor (Rare Tumors 2011;3:e26)
● 60 year old woman with primary cutaneous tumor of leg
(Am J Surg Pathol 2002;26:938)
● 72 year old woman with tumor of uterine corpus
(Pathol Int 2011;61:377)
Treatment and prognosis
=========================================================================
● Overall poorer prognosis than embryonal subtype
● Intergroup Rhabdomyosarcoma Study grouping (staging) is predictive of outcome
● Poor prognostic factors: N-myc amplification, PAX3 fusion transcripts
(J Clin Oncol 2002;20:2672)
● Mixed forms with alveolar component are classified as alveolar for staging and diagnosis
Clinical images
=========================================================================
|
Multiple nodules on foot |
Progressive enlargement of skin lesions |
Paranasal lesion |
Gross description
=========================================================================
● Fleshy, tan-gray, mean 5 cm
Gross images
=========================================================================
Congenital post-auricular tumor
Micro description
=========================================================================
● Thin fibrous septae lined by small round blue cells (resembling lymphoma) in an alveolar growth pattern (resembles pulmonary alveoli)
● Loss of cellular cohesion so cells appear to float in alveolar spaces
● Also peripheral cracking artifact at borders of cell clusters
● Amount of alveolar tissue present is NOT significant (i.e. diagnose as alveolar even if only focal alveolar pattern)
● Deep eosinophilic cytoplasm and presence of occasional multinucleated giant cells are important diagnostic features
● 1/3 have rhabdomyoblasts with cytoplasmic cross striations
● Often foci of coagulative tumor cell necrosis
● May have neuroendocrine differentiation
(Int J Surg Pathol 2009;17:135)
● Mixed embryonal / alveolar: have foci with embryonal histology (spindle cell myoblasts, myxoid stroma)
● Rarely has rhabdoid features (pink, ground-glass or fibrillar round to oval cytoplasmic bodies, large eosinophilic nucleoli)
Micro images
=========================================================================
Tumor cells grow in nests or clusters separated by fibrous septa (AFIP)
Solid growth (AFIP)
Cytology images
=========================================================================
Positive stains
=========================================================================
● Muscle specific actin, desmin, myogenin (strong nuclear staining,
Am J Surg Pathol 2001;25:1150)
● Myo-D1
(Am J Surg Pathol 2006;30:962),
ALK1
● Also CAM 5.2 and broad spectrum cytokeratin (50%), neuroendocrine markers (43% express at least one,
Mod Pathol 2008;21:795),
p80 (25%, cytoplasmic dot-like pattern,
Mod Pathol 2002;15:931),
PAX5 (67%,
Am J Surg Pathol 2009;33:775)
Electron microscopy description
=========================================================================
● Skeletal muscle differentiation
Molecular / cytogenetics description
=========================================================================
● t(2;13)(q35;q14): PAX3-FKHR in 60-85% (note: FKHR is now known as FOXO1)
● t(1;13)(p36;q14): PAX7-FKHR in 15-20%
● PAX/FKHR fusion negativity in 20% (associated with totally solid alveolar architecture,
Am J Surg Pathol 2007;31:895)
● N-myc amplification in 50%
● P-cadherin is a direct PAX3-FOXO1A transcriptional target involved in alveolar RMS aggressiveness
(Oncogene 2012 Jun 18 [Epub ahead of print])
Molecular images
=========================================================================
2;13 translocation; G-banding (above); R- banding (below) |
t(2;13)(q35;q14) and t(1;13)(p36;q14) |
Comparison of wild-type and fusion products associated with t(2;13) and t(1;13) |
FISH |
FISH |
Videos
=========================================================================
Dr. Minarcik reviews skeletal muscle of face and alveolar rhabdomyosarcoma
Differential diagnosis
=========================================================================
● Alveolar soft parts sarcoma: PAS+ intracytoplasmic crystalline rods and granules; no pleomorphism, no giant cells, no fibrous septa, negative for muscle specific actin and myoglobin
● Merkel cell carcinoma: negative for muscle specific actin, desmin, myogenin and Myo-D1, lacks fusion gene
● Metastatic neuroendocrine carcinoma: keratin+, EMA+, desmin-, muscle specific actin-, lacks fusion gene
Anaplastic variant
Definition
=========================================================================
● Alveolar rhabdomyosarcoma with anaplastic nuclei
● Not a well characterized entity
Treatment and prognosis
=========================================================================
● Prognosis may be worse than typical alveolar rhabdomyosarcoma
Micro description
=========================================================================
● Anaplastic nuclei are 3x larger than surrounding nuclei
Micro images
=========================================================================
Foci of anaplastic cells (nuclei are hyperchromatic and 3x larger than surrounding cells)
Solid variant
Clinical features
=========================================================================
● Rarely occurs in adults in head and neck
(Hum Pathol 2009;40:341)
Case reports
=========================================================================
● 16 year old girl with chest and foot masses (Univ Pittsburgh Case #256)
● 68 year old man with mediastinal tumor (J Cancer Res Ther 2011;7:353)
Micro description
=========================================================================
● Poorly developed alveolar pattern, lacks fibrovascular septa
● Alveolar pattern may be missed on small biopsies
● May resemble lymphoma
(J Pediatr Hematol Oncol 2008;30:772)
● Solid component may be spindled sarcomatous to epitheloid cells
(J Cancer Res Ther 2011;7:353)
Micro images
=========================================================================
Positive stains
=========================================================================
● Desmin and muscle specific actin
● May be CD56+ (J Clin Exp Hematop 2008;48:61)
● MyoD1 and myogenin may be positive
Molecular description
=========================================================================
● Associated with lack of fusion gene
(Am J Surg Pathol 2007;31:895)
Molecular images
=========================================================================
FISH and karyotype show t(2;13)
End of Soft tissue tumors > Skeletal muscle > Alveolar rhabdomyosarcoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).